Defining a hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

Sally Arai, Michelle Fanale, Sven Devos, Andreas Engert, Tim Illidge, Peter Borchmann, Anas Younes, Franck Morschhauser, Alex McMillan, Sandra J. Horning